Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma (NCT06037941)
Breathprinting (E-Nose) Technology to Measure Response to Treatment of Malignant Pleural Mesothelioma (MPM) Through MPM-Specific Volatile Organic Compounds Detected in Exhalates
🩺 Plain-English Summary (8th-Grade Level)
The researchers are doing this study to test the ability of a new technology called breathprinting, or electronic nose (E-Nose), to measure how people respond to standard treatment for malignant pleural mesothelioma (MPM). The researchers will study how E-Nose breathprints change over time as people receive standard treatment for MPM. They will also look at how changes in people's E-Nose breathprints compare to changes in their standard imaging scans and in biomarkers of MPM in their blood.
Who can join: Review the eligibility criteria below.
Location: Memorial Sloan Kettering Basking Ridge (Consent Only) — Basking Ridge, New Jersey
Age range: 30 Years to 85 Years
🧪 Interventions in This Study
- E-Nose testing (DIAGNOSTIC_TEST)
- Research blood (DIAGNOSTIC_TEST)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- Memorial Sloan Kettering Basking Ridge (Consent Only) — Basking Ridge, New Jersey
- Memorial Sloan Kettering Monmouth (Consent Only) — Middletown, New Jersey
- Memorial Sloan Kettering Bergen (Consent Only ) — Montvale, New Jersey
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent Only) — Commack, New York
- Memorial Sloan Kettering Westchester (Consent Only) — Harrison, New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York
- Memorial Sloan Kettering Nassau (Consent Only) — Uniondale, New York
📞 Contact the Study Coordinator
Phone: (212) 639-3478
Email: roccog@mskcc.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Malignant Pleural Mesothelioma
- A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma — Basking Ridge, New Jersey
- A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma — Basking Ridge, New Jersey
- OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition — Philadelphia, Pennsylvania
Explore by condition: All Malignant Pleural Mesothelioma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.